• EnglishEnglish
    • Deutsch Deutsch
    • Italiano Italiano
    • Français Français
    • 日本語 日本語
    • 한국어 한국어

CISEMA - China Zertifizierung, Einkauf und Qualitätssicherung

  • Services
    • NMPA Registration – Medical Devices and IVDs
    • NMPA Registration & DMF – Pharmaceuticals
    • NMPA Registration – Cosmetics
    • NMPA Registration – Health Food
    • CML (China Manufacture Licence) – Pressure vessels
    • CCC (China Compulsory Certification) – Industrial and consumer goods
    • Others
      • Sourcing and Quality Control
      • Logistics and Customs Support
      • Sales Support
  • Events
    • Trade Fairs & Conferences
    • Seminars
    • Webinars
  • News & Knowledge
    • Regulatory News
      • Medical Devices and IVDs
      • Cosmetics
      • Pharmaceuticals & DMF
      • CCC
      • Pressure Vessels
    • Whitepapers
    • FAQ – NMPA Registration – Medical Devices and IVDs
    • Newsletter Sign Up
    • Others
      • Publications
      • Online Shop
  • About us
    • Partners
    • Company Profile
    • Testimonials
  • Locations
  • Newsletter Sign Up
Contact
  • Home
  • News
  • News
  • NMPA Registration in China
  • Medical Device
  • December 2021 Regulatory Roundup for Medical Device Mandatory Standards

December 2021 Regulatory Roundup for Medical Device Mandatory Standards

China Medical Device Standards
Tuesday, 25 January 2022 / Published in Medical Device, News, NMPA Registration in China

December 2021 Regulatory Roundup for Medical Device Mandatory Standards

On December 14, 2021, the NMPA (National Medical Products Administration) published a draft list of 76 standards associated to GB 9706.1-2020 to solicit public comments. The GB 9706.1-2020 medical electrical equipment Part 1: General requirements for basic safety and basic performance was issued on April 9, 2020, and will be implemented on May 1, 2023. Aside from GB 9706.1-2020 itself, the draft list consists of 68 specialized standards and 7 collateral standards. According to the implementation measures proposed by the NMPA,

  • The date of implementation for GB 9706.1-2020 and its collateral standards will be May 1, 2023.
  • Specialized standards under GB9706.1-2020 are indicated as standards with special requirements which will be further clarified when the draft is finalized.

On December 1, 2021, the Standardization Administration approved and issued (No.15-2021) 8 national standards for medical devices:

  1. GB 9706.202-2021 Medical electrical equipment – Part 2-2: Particular requirements for basic safety and basic performance of high frequency surgical equipment and high frequency accessories
  2. GB 9706.213-2021 Medical electrical equipment – Part 2-13: Particular requirements for the basic safety and basic performance of anesthesia workstations
  3. GB 9706.218-2021 Medical electrical equipment – Part 2-18: Particular requirements for the basic safety and basic performance of endoscopic equipment
  4. GB 9706.224-2021 Medical electrical equipment – Part 2-24: Particular requirements for the basic safety and basic performance of infusion pumps and infusion controllers
  5. GB 9706.225-2021 Medical electrical equipment – Part 2-25: Particular requirements for the basic safety and basic performance of electrocardiographs
  6. GB 9706.236-2021 Medical electrical equipment – Part 2-36: Particular requirements for the basic safety and basic performance of extracorporeal lithotripsy equipment
  7. GB 11236-2021 Technical requirements and test methods of copper IUD
  8. GB 14232.4-2021 Plastic bag containers for human blood and blood components – Part 4: single blood bag system with special components

On December 10, 2021, the NMPA approved and issued (No.144-2021) 19 industry standards for medical devices:

  1. YY/T 1747-2021 Neurovascular implants Intracranial artery stents
  2. YY/T 1784-2021 Blood gas analyzer
  3. YY/T 1789.2-2021 In Vitro Diagnostic Test System Performance Evaluation Method Part 2: Accuracy
  4. YY/T 1791-2021 Hepatitis B virus e antibody detection kit (luminescence immunoassay)
  5. YY/T 1801-2021 Fetal chromosome aneuploidy trisomy 21, trisomy 18 and trisomy 13 detection kit (high-throughput sequencing method)
  6. YY/T 1820-2021 Specific antinuclear antibody IgG detection kit (Western blotting)
  7. YY/T 1824-2021 EB virus nucleic acid detection kit (fluorescence PCR method)
  8. YY/T 1825-2021 Red blood cell and white blood cell count reference measurement procedure fixed value result measurement uncertainty evaluation guide
  9. YY/T 1826-2021 Group B Streptococcus Nucleic Acid Detection Kit (Fluorescence PCR Method)
  10. YY/T 1828-2021 Anti-Mullerian hormone determination kit (chemiluminescence immunoassay)
  11. YY/T 1831-2021 Syphilis spirochete antibody detection kit (immunochromatographic method)
  12. YY/T 1836-2021 Respiratory virus multiple nucleic acid detection kit
  13. YY/T 0500-2021 Cardiovascular implants: Vascular prostheses – Tubular vascular grafts and vascular patches
  14. YY/T 0647-2021 Passive surgical implants: Specific requirements for breast implants
  15. YY/T 0701-2021 Calibrator for blood analyzer
  16. YY/T 1160-2021 Carcinoembryonic Antigen (CEA) Assay Kit
  17. YY/T 1164-2021 Human chorionic gonadotropin (HCG) detection kit (colloidal gold immunochromatographic method)
  18. YY/T 1180-2021 Human Leukocyte Antigen (HLA) Genotyping Test Kit
  19. YY/T 1204-2021 Kit for determination of total bile acid

The code name of the mandatory national standard is “GB”, and the recommended national standard is “GB/T”. The code name of the mandatory industry standard is “YY”, and the code name of the recommended industry standard is “YY/T”. Contact Cisema if you would like to learn more about the compliance requirements for your medical product in China.

By Alice Liu and Jacky Li.

Tagged under: Guobiao, Mandatory Standards, YY

What you can read next

Registration of Infant Formula Milk Powder in China
Quality assurance in purchasing China products
IHK for Bavaria & Cisema Webinar: Online Procurement in China – Quality assurance in purchasing
china cosmetics label requirements
China Cosmetics Label Requirements for Ingredients added to Cosmetic Raw Materials

Search

Categories

  • Fairs & Events
  • News
    • CCC
    • CEL
    • CML, SELO
    • Medical Devices Listing in Hong Kong
    • NMPA Registration in China
      • Cosmetics
      • Health Food
      • Medical Device
      • Pharmaceuticals & DMF
    • RoHS
    • Voluntary Product Certification
  • Publications
  • Seminars
  • Uncategorized
  • Webinars

Recent Posts

  • Submission of safety information for cosmetics ingredients

    Submission of safety information for cosmetics raw materials – Draft guidelines issued

    Submission of safety information for cosmetics ...
  • avoid animal testing in Chinaweb-2023

    How to avoid animal testing in China for cosmetics | Cisema Webinar

    China’s beauty and cosmetic market has be...
  • guidelines for medical devices registration

    Guidelines for medical devices registration in China – New development plans in 2023

    Guidelines for medical devices registration in ...
  • China DMF of API

    China DMF of API, Excipient & Packaging Materials: Market & Regulatory | Cisema Webinar

    “China DMF of API, Excipient & Packag...
  • pre-phase III drug clinical trial meeting guidelines

    Pre-phase III drug clinical trial meeting guidelines released

    Pre-phase III drug clinical trial meeting guide...

Archive

Cisema

With twelve locations and over ninety highly qualified employees, Cisema can offer you optimal support in China.

Services

  • Certification
  • Sourcing and Quality Control
  • Logistics and Customs Support
  • Sales Support

Dialogue

  • Contact us
  • Newsletter Signup
  • Events
  • News & Knowledge
  • Partners

Company

  • GTC
  • Privacy Statement
  • Legal Notice
  • About us
  • Locations
  • GET SOCIAL

© 2021 Cisema. All rights reserved.

TOP